SpendMend Adds Multiple Solutions to Conductiv Agreement

SpendMend, the leading provider of solutions to optimize the cost-cycle for hospitals and healthcare networks, today announced an expansion of their solution offerings through Conductiv, the nation’s only end-to-end third-party lifecycle improvement company.

SpendMend holds the distinction as the first healthcare industry provider to have been awarded a group purchasing agreement with Conductiv Contracts. Building on several years of joint success, Conductiv is now promoting SpendMend’s Medical Device Explant Tracking, Pharmacy Spend Optimization as well as multiple 340B solutions to Conductiv’s vast nationwide membership.

“We’re always pleased to expand our catalogue of value-generating supplier solutions,” says Mickey Meehan, COO, Conductiv, “for years, we’ve recognized the consistency and quality of SpendMend’s offerings, and we’re excited to build on our successful relationship and drive additional value to our members.”

“We admire Conductiv’s unique approach, uniting an alliance of buyers and suppliers to help reshape how healthcare systems acquire services,” states Dan Geelhoed, CEO of SpendMend. “By adding more of our solutions into group purchasing agreements with Conductiv, we know we will drive more value to hospitals and ultimately that means we are helping those facilities to better fund patient care.”

The expanded solution offering is immediately available to the entire network of Conductiv member hospitals and healthcare facilities.

SourceSpendMend

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”